AbbVie : ABBV

All AbbVie Articles

616 Articles

Jon C. Ogg | Nov 10, 2020 at 8:59 AM EST

Top Analyst Upgrades and Downgrades: AbbVie, Beyond Meat, Biogen, Cars.com, Levi Strauss, Maxeon, Nvidia, Pfizer, Plug Power, Square, Wayfair and More

Tuesday's top analyst upgrades and downgrades included AbbVie, Beyond Meat, Biogen, Eli Lilly, Levi Strauss, Nvidia, Pfizer, Plug Power, Raytheon,…

Jon C. Ogg | Nov 4, 2020 at 12:46 PM EST

6 Health Care Stocks That Won Massively From the 2020 Election

Here are six health care stocks that appear to be specific winners based on a mixed Congress, regardless of which…

Jon C. Ogg | Nov 2, 2020 at 9:05 AM EST

Top Analyst Upgrades and Downgrades: AbbVie, Alibaba, ADM, Best Buy, Intel, Lemonade, Nikola, Peloton, SAP, Under Armour, Wynn and More

Monday's top analyst upgrades and downgrades included AbbVie, Alibaba, Archer Daniels Midland, Best Buy, Intel, Nikola, Peloton Interactive, SAP, Under…

Lee Jackson | Oct 14, 2020 at 8:29 AM EDT

Wall Street Fund Managers Love These 5 Large Cap Health Care Stocks

Health care is one sector that continues to draw a ton of fund manager interest, and with good reason. These…

Lee Jackson | Oct 5, 2020 at 9:50 AM EDT

Top Analyst Very Positive on Leading Medical Technology Health Care Stocks for 2021

These five high-conviction medical technology health care ideas from Jefferies all make sense for investors looking to gain exposure to…

Jon C. Ogg | Sep 29, 2020 at 9:05 AM EDT

Top Analyst Upgrades and Downgrades: AbbVie, CSX, Dominion, JPMorgan, NXP, ONEOK, Pfizer, Square, UPS, WPX Energy and More

Tuesday's top analyst upgrades and downgrades included AbbVie, CSX, Dominion Energy, JPMorgan, NXP Semiconductors, ONEOK, Pfizer, Square, United Parcel Service…

Lee Jackson | Sep 16, 2020 at 7:30 AM EDT

5 Dividend Aristocrat Stocks That Are Quietly Offering Huge Total Return Potential

These five Dividend Aristocrats have sizable upside to the Wall Street targets and pay at least 4%. In a market…

Paul Ausick | Sep 10, 2020 at 8:12 AM EDT

8 Overlooked Companies That Keep Raising Dividends Ever Higher

A hot equity market from some popular stocks has overshadowed the steady payouts from many, less spectacular, but reliable companies.…

Lee Jackson | Aug 27, 2020 at 8:50 AM EDT

Why Dividend-Paying Big Drug Companies May Be the Best Stocks to Own Now

These five dividend-paying large-cap pharmaceutical stocks look like outstanding ideas for nervous investors looking for income and a degree of…

Jon C. Ogg | Aug 3, 2020 at 9:18 AM EDT

Top Analyst Upgrades and Downgrades: AbbVie, DuPont, Etsy, Expedia, Exxon, Kansas City Southern, Merck, Microsoft, Pinterest, Qualcomm, SolarEdge, Visa, Yum and More

Monday's top analyst upgrades and downgrades included AbbVie, DuPont, Etsy, Expedia, Exxon Mobile, Kansas City Southern, Merck, Microsoft, Pinterest, Qualcomm,…

Chris Lange | Jul 26, 2020 at 6:31 AM EDT

AbbVie, Eli Lilly, Gilead, and More Biopharma Stocks Reporting Earnings This Week

Earnings season is in full swing, and we have put together a preview of some of the world’s largest players…

Jon C. Ogg | Jun 23, 2020 at 9:09 AM EDT

Top Analyst Upgrades and Downgrades: AbbVie, Ambarella, Apple, DocuSign, Home Depot, Lowe’s, Micron, Nike, PG&E, ViacomCBS, YETI, Yext and More

Tuesday's top analyst upgrades and downgrades included AbbVie, Ambarella, Apple, DocuSign, Home Depot, Lowe's, Micron Technology, Nike, PG&E, ViacomCBS, YETI…

Chris Lange | Jun 18, 2020 at 10:21 AM EDT

Has Alpine Immune Sciences Found the Deal of a Lifetime?

Alpine Immune Sciences shares doubled on Thursday after the company announced a license agreement with AbbVie for its ALPN-101.

Jon C. Ogg | Jun 2, 2020 at 11:29 AM EDT

Why AbbVie Could Have the Most Upside Among Big Pharma Stocks

Some mergers can add a nice shot in the arm for an acquirer. After years of being focused on Humira,…

Jon C. Ogg | Jun 2, 2020 at 8:53 AM EDT

Top Analyst Upgrades and Downgrades: AbbVie, ANGI, CBOE, Darden, Hess, Lululemon, MongoDB, PayPal, Shopify, Slack, Zynga and More

Tuesday's top analyst upgrades and downgrades included AbbVie, ANGI Homeservices, CBOE, Darden Restaurants, Hess, Lululemon Athletica, MongoDB, PayPal, Shopify, Slack…

1 … 14 15 16 17 18 … 42

AbbVie : ABBV

All AbbVie Articles

Top Analyst Upgrades and Downgrades: AbbVie, Beyond Meat, Biogen, Cars.com, Levi Strauss, Maxeon, Nvidia, Pfizer, Plug Power, Square, Wayfair and More

6 Health Care Stocks That Won Massively From the 2020 Election

Top Analyst Upgrades and Downgrades: AbbVie, Alibaba, ADM, Best Buy, Intel, Lemonade, Nikola, Peloton, SAP, Under Armour, Wynn and More

Wall Street Fund Managers Love These 5 Large Cap Health Care Stocks

Top Analyst Very Positive on Leading Medical Technology Health Care Stocks for 2021

Top Analyst Upgrades and Downgrades: AbbVie, CSX, Dominion, JPMorgan, NXP, ONEOK, Pfizer, Square, UPS, WPX Energy and More

5 Dividend Aristocrat Stocks That Are Quietly Offering Huge Total Return Potential

8 Overlooked Companies That Keep Raising Dividends Ever Higher

Why Dividend-Paying Big Drug Companies May Be the Best Stocks to Own Now

Top Analyst Upgrades and Downgrades: AbbVie, DuPont, Etsy, Expedia, Exxon, Kansas City Southern, Merck, Microsoft, Pinterest, Qualcomm, SolarEdge, Visa, Yum and More

AbbVie, Eli Lilly, Gilead, and More Biopharma Stocks Reporting Earnings This Week

Top Analyst Upgrades and Downgrades: AbbVie, Ambarella, Apple, DocuSign, Home Depot, Lowe’s, Micron, Nike, PG&E, ViacomCBS, YETI, Yext and More

Has Alpine Immune Sciences Found the Deal of a Lifetime?

Why AbbVie Could Have the Most Upside Among Big Pharma Stocks

Top Analyst Upgrades and Downgrades: AbbVie, ANGI, CBOE, Darden, Hess, Lululemon, MongoDB, PayPal, Shopify, Slack, Zynga and More

The American Chip Boom Picks Winners: TXN, INTC, and QRVO at Current Share Prices

NVIDIA is Acquiring ‘Dark Fiber’ Across the United States. Here’s Why That’s a Big Deal.

SpaceX Just Erased $1 Trillion in Value. Here’s Why the Worst Could Be Yet to Come.

If Social Security Cuts Benefits, Here's Who Might Get Hurt the Most

Peter Thiel Turned a $2,000 Roth IRA Into $5 Billion and Will Never Owe a Penny of Tax. The Same Rules Apply to Your Account

The American Chip Boom Picks Winners: TXN, INTC, and QRVO at Current Share Prices

NVIDIA is Acquiring ‘Dark Fiber’ Across the United States. Here’s Why That’s a Big Deal.

AbbVie : ABBV

All AbbVie Articles

Top Analyst Upgrades and Downgrades: AbbVie, Beyond Meat, Biogen, Cars.com, Levi Strauss, Maxeon, Nvidia, Pfizer, Plug Power, Square, Wayfair and More

6 Health Care Stocks That Won Massively From the 2020 Election

Top Analyst Upgrades and Downgrades: AbbVie, Alibaba, ADM, Best Buy, Intel, Lemonade, Nikola, Peloton, SAP, Under Armour, Wynn and More

Wall Street Fund Managers Love These 5 Large Cap Health Care Stocks

Top Analyst Very Positive on Leading Medical Technology Health Care Stocks for 2021

Top Analyst Upgrades and Downgrades: AbbVie, CSX, Dominion, JPMorgan, NXP, ONEOK, Pfizer, Square, UPS, WPX Energy and More

5 Dividend Aristocrat Stocks That Are Quietly Offering Huge Total Return Potential

8 Overlooked Companies That Keep Raising Dividends Ever Higher

Why Dividend-Paying Big Drug Companies May Be the Best Stocks to Own Now

Top Analyst Upgrades and Downgrades: AbbVie, DuPont, Etsy, Expedia, Exxon, Kansas City Southern, Merck, Microsoft, Pinterest, Qualcomm, SolarEdge, Visa, Yum and More

AbbVie, Eli Lilly, Gilead, and More Biopharma Stocks Reporting Earnings This Week

Top Analyst Upgrades and Downgrades: AbbVie, Ambarella, Apple, DocuSign, Home Depot, Lowe’s, Micron, Nike, PG&E, ViacomCBS, YETI, Yext and More

Has Alpine Immune Sciences Found the Deal of a Lifetime?

Why AbbVie Could Have the Most Upside Among Big Pharma Stocks

Top Analyst Upgrades and Downgrades: AbbVie, ANGI, CBOE, Darden, Hess, Lululemon, MongoDB, PayPal, Shopify, Slack, Zynga and More

The American Chip Boom Picks Winners: TXN, INTC, and QRVO at Current Share Prices

NVIDIA is Acquiring ‘Dark Fiber’ Across the United States. Here’s Why That’s a Big Deal.

SpaceX Just Erased $1 Trillion in Value. Here’s Why the Worst Could Be Yet to Come.

Featured Reads

If Social Security Cuts Benefits, Here's Who Might Get Hurt the Most

Peter Thiel Turned a $2,000 Roth IRA Into $5 Billion and Will Never Owe a Penny of Tax. The Same Rules Apply to Your Account